A randomised controlled trial study to compare the effects of Dhaka Regimen in comparison to Zuspan regimen in prevention of Pregnancy induced hypertensive seizures/ fits.

EFFICACY OF DHAKA REGIMEN IN COMPARISON TO ZUSPAN REGIMEN IN PREVENTION OF ECLAMPSIA :A RANDOMIZED CONTROL TRIAL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/018950

Enrollment

Registered

2019-05-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O141- Severe pre-eclampsia

Interventions

Intervention1: Group 1: Group 1 will receive: Loading Dose-Inj MgSO4 4gm IV over 10 mins and followed by MgSO4 3 gm IM in each buttock Maintenance Dose: Inj MgSO4 2.5 gm in alternate buttock every

Eligibility

Inclusion criteria

Inclusion criteria: All ANC cases with severe pre eclampsia

Exclusion criteria

Exclusion criteria: ANC cases with deranged renal function test, coagulation profile and seizure disoder

Design outcomes

Primary

Measure	Time frame
prevention of eclampsiaTimepoint: 18 months	—

Secondary

Measure	Time frame
Maternal outcomes: Mg toxicity, Oliguria, Mode of delivery Fetal : Live birth, still born, perinatal mortality, NICU admissions requiring more than 24 hrsTimepoint: 1 yr 6months	—

Countries

India

Contacts

Public ContactSOUVIK NANDY

Armed Forces Medical College

docatulseth@yahoo.com8390433228

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026